Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
NB
NP Bioinnovation A/S
aktivCVR 41598263AktieselskabVandtårnsvej 62A, 1 b, 2860 SøborgFremstilling af farmaceutiske præparater
- Latest accounts
- 2026
- Statement scope
- Standalone
- Verified
- 12 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2026
Revenue
Data quality concern—
Data quality concern
Operating profit
DKK -5.4m
Latest period
Source details
Source: dk-regnskabsdata-live-41598263-1794491262939
Document: dk-regnskabsdata-41598263-AaD3V3zpntWaBrQWhmug-1
XBRL: d:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Apr 2025 - 31 Mar 2026
Technical details
Context: c11
Unit: u3
Net result
DKK -5.5m
Latest period
Source details
Source: dk-regnskabsdata-live-41598263-1794491262939
Document: dk-regnskabsdata-41598263-AaD3V3zpntWaBrQWhmug-1
XBRL: d:ProfitLoss
Period: 01 Apr 2025 - 31 Mar 2026
Technical details
Context: c11
Unit: u3
Equity
DKK -5.4m
Equity ratio: -63.1%
Source details
Source: dk-regnskabsdata-live-41598263-1794491262939
Document: dk-regnskabsdata-41598263-AaD3V3zpntWaBrQWhmug-1
XBRL: d:Equity
Period: 01 Apr 2025 - 31 Mar 2026
Technical details
Context: c49
Unit: u3
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2023 | — | DKK -88.9k |
| 2024 | — | DKK -80.3k |
| 2025 | — | DKK -60.1k |
| 2026 | — | DKK -5.5m |